Table 1.
Protein substrate | Regulators | Full name | Post-transcriptional modification | Effects of the modifications | References |
---|---|---|---|---|---|
Drp1 | CDK1 | Cyclin-dependent kinase 1 | Phosphorylation of Ser 616 | Activation | 184 |
PKA | Protein kinase A | Phosphorylation of Ser637 | Inactivation | 185 | |
DNA-PKcs | DNA-dependent protein kinase, catalytic subunit | Phosphorylation of Ser616 | Activation | 186 | |
O-GlcNAc transferase or OGT |
uridine diphospho-N-acetylglucosamine:polypeptide β-N-acetylglucosaminyltransferase | O-GlcNAcylation of Drp1 at Thr585/586 | Activation | 187 | |
MAPL | Mitochondria-associated protein ligase | SUMOylation of Drp1 | Activation | 188 | |
SENP5 | SUMO-specific Peptidase 5 | De-SUMOylation of Drp1 | Inactivation/stabilization | 189 | |
March5 | Membrane associated RING finger protein 5 | Ubiquitination of Drp1 | Degradation | 190 | |
Mfn1 | ERK | Extracellular-signal-regulated kinase 1/2 | Phosphorylation of T562 | Inactivation | 191 |
March5 | Membrane associated RING finger protein 5 | Ubiquitin of Mfn1 | Degradation | 192 | |
Mfn2 | PINK1 | PTEN-induced kinase 1 | Phosphorylation of Thr111 and Ser442 | Signaling | 193 |
March5 | Membrane associated RING finger protein 5 | Ubiquitin of Mfn2 | Activation | 194 | |
Mfn1/2 | USP30 | Ubiquitin specific peptidase 30 | Deubiquitin of Mfn1/2 | Inactivation | 195 |
Mff | NR4A1 | Nuclear receptor subfamily 4 group A member 1 | Phosphorylation of Ser146 | Activation | 196 |